Lynne Powell - 15 Jun 2022 Form 4 Insider Report for BIORA THERAPEUTICS, INC. (BIORQ)

Role
Director
Signature
/s/ Will Pridgen, Attorney-in-Fact for Lynne Powell
Issuer symbol
BIORQ
Transactions as of
15 Jun 2022
Net transactions value
$0
Form type
4
Filing time
17 Jun 2022, 16:30:38 UTC
Previous filing
16 Jun 2021
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIOR Common Stock Award $0 +96,154 +202% $0.000000 143,672 15 Jun 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOR Stock Option (Right to Buy) Award $0 +148,810 $0.000000 148,810 15 Jun 2022 Common Stock 148,810 $0.6400 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 96,154 restricted stock units, which vest in full on the earlier of (1) June 15, 2023 or (2) the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.
F2 This option represents the right to purchase 148,810 shares of the Issuer's common stock, which vest in full on the earlier of (1) June 15, 2023 or (2) the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.